Interpace Diagnostics Group
- Surgical and Medical Instruments and Apparatus
- Parsippany, New Jersey
Compensation history
Top executives at Interpace Diagnostics Group received an average of $575K per person in annual compensation from 2015 to 2023.
Average pay of disclosed executives at Interpace Diagnostics Group
By year
Executives
We found nine executives who work or worked at Interpace Diagnostics Group.
Thomas Burnell
Interpace Diagnostics Group
Chief Executive Officer
Christopher McCarthy
Interpace Diagnostics Group
Chief Financial Officer
Thomas Freeburg
Interpace Diagnostics Group
Chief Financial Officer
Fred Knechtel
Interpace Diagnostics Group
Chief Financial Officer
Jack Stover
Interpace Diagnostics Group
Chief Executive Officer
James Early
Interpace Diagnostics Group
Chief Financial Officer
Gregory Richard
Interpace Diagnostics Group
Chief Commercial Officer
Graham Miao
Interpace Diagnostics Group
Chief Financial Officer
News
Interpace Diagnostics Group CEO Thomas Burnell's 2023 pay rises 7% to $678K
September 20, 2024
Interpace Diagnostics Group CEO Thomas Burnell's 2022 pay rises 8% to $634K
September 22, 2023
Interpace Diagnostics Group CFO Thomas Freeburg's 2021 pay jumps 329% to $771K
September 20, 2022
Interpace Diagnostics Group CEO Jack Stover's 2019 pay falls 34% to $862K
June 9, 2020
Interpace Diagnostics Group CEO Jack Stover's 2018 pay falls 36% to $1.3M
August 22, 2019
About Interpace Diagnostics Group
- Industry classifications
- DivisionManufacturing
- Major groupMeasuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
- Industry groupSurgical, Medical, And Dental Instruments And Supplies
- IndustrySurgical and Medical Instruments and Apparatus
- AddressWaterview Plaza, Suite 310, 2001 Route 46, Parsippany, New Jersey 07054
- Phone412-224-6100
- Fiscal year endDecember 31
- Former names
- Interpace Diagnostics Group, Inc.Until October 31, 2019
- PDI INCUntil December 21, 2015
- PROFESSIONAL DETAILING INCUntil November 12, 2002
Source: SEC filings on September 20, 2024, September 22, 2023, September 20, 2022, June 9, 2020, August 22, 2019, April 30, 2018, and August 14, 2017.